UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 25, 2014
|
(Exact name of registrant as specified in its charter) |
| | |
| | |
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
| | |
995 E. Arques Avenue, Sunnyvale, California | |
(Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (408) 774-0330
|
(Former name or former address, if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On August 25, 2014, the Compensation Committee of the Board of Directors of Pharmacyclics, Inc. (the “Company”) approved 2014 mid-year cash bonuses for certain officers of the Company, including $151,742 for Mahkam Zanganeh, the Company’s Chief Operating Officer, $126,452 for Manmeet Soni, the Company’s Chief Financial Officer, and $105,714 for Heow Tan, the Company’s Chief of Quality and Technical Operations.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
August 29, 2014
PHARMACYCLICS, INC. |
|
|
By: | /s/ Manmeet Soni |
| Name: Manmeet Soni |
| Title: Chief Financial Officer |